News

Ablation Catheters, Atrial Fibrillation, EP Lab, FlexAbility Ablation Catheter

St. Jude Medical Inc. announced U.S. Food and Drug Administration (FDA) approval of the FlexAbility Ablation Catheter, a new ablation technology used by electrophysiologists for the treatment of...

ECRI Institute has released an updated comparison on cardiac resuscitators used during cardiopulmonary resuscitation (CPR).

FEops, TAVIguide, Series A financing, navigation, advanced visualization

FEops announced the closing of a €1.3 million (~$1.9 million USD) series A financing round, led by Capricorn Venture Partners and PMV. The funding will be used to support the launch of FEops’...

St. Jude, STAR-VT, ventricular tachycardia, ablation catheter, FlexAbility

St. Jude Medical Inc. announced the first patient enrollment in the STAR-VT (Substrate Targeted Ablation using the FlexAbility Ablation...

Clinical trial/study, EP Lab, WRAP Infection Clinical Trial

Medtronic Inc. announced the first patient enrollment in the WRAP Infection Clinical Trial, which will evaluate the effectiveness of the TYRX Absorbable Antibacterial Envelope in reducing major...

CVRx, Barostim neo Legacy System, pacemaker, hypertension, FDA, HDE

The U.S. Food and Drug Administration (FDA) has granted a humanitarian device exemption for the CVRx Inc. Barostim neo Legacy System.

Savaysa, Daiichi Sankyo, edoxaban, FDA, approval, NVAF, thromboembolism

Daiichi Sankyo Co. Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved Savaysa (edoxaban) tablets, an oral, once-daily selective factor Xa-inhibitor, to reduce the risk of...

CardioFocus, HeartLight Endoscopic Ablation System, Japan Lifeline, distribution

CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System for the treatment of atrial fibrillation (AF), announced that it has executed an exclusive, multi-year distribution...

Ablation Systems, Atrial Fibrillation, EP Lab, Clinical Trial/Study

Medtronic, Inc. announced the initiation of a randomized clinical trial in Europe to assess the benefits of ablation using the Medtronic Artic Front Advance cryoballoon as a first-line treatment...

Biotronik announced the publication of new findings from the REPLACE Registry in Circulation: Arrhythmia and Electrophysiology. The Biotronik-sponsored REPLACE Registry...

absorb, bioresorbable stents

DAIC readers chose the following stories as the most popular content in 2014, based on website analytics. The list is broken into the top 20 most popular news items from 2014 and a list of the top...

Hemodynamic support devices, Resuscitation Devices, Zoll Medical Corp.

Zoll Medical Corp. announced that it will acquire Advanced Circulatory Systems Inc.

Philips has signed an agreement with Image Stream Medical (ISM) that allows Philips to further expand its hybrid suite and interventional lab solutions with integrated video and live...

Advanced Vascular Dynamics, RadAR vascular compression device

Advanced Vascular Dynamics (AVD) announced U.S. Food and Drug Administration (FDA) clearance and CE mark for the RadAR vascular compression devices for post-procedure hemostasis of tibiopedal...

AliveCor Heart Monitor, third generation, ECG, atrial fibrillation, AF

AliveCor Inc. announced the launch of its third-generation AliveCor Heart Monitor. Now users have the ability to identify and manage heart conditions with a U.S. Food and Drug Administration...

Atrial fibrillation, heart valve repair, software, mobile devices, ACC app

The American College of Cardiology’s recently released Guideline Clinical App has expanded with the addition of tools and guideline content for two conditions, valvular heart disease and...

EP Lab, Atrial Fibrilation, RhythmView 3-D Mapping System, MIP Award

Topera, Inc. announced that its RhythmView 3-D Mapping System received the Most Innovative New Product (MIP) Award at the 2014 CONNECT MIP Awards.

St. Jude Medical Inc. announced CE Mark approval of the Quadra Allure MP cardiac resynchronization therapy pacemaker (CRT-P). The Quadra Allure MP is a quadripolar CRT-P with the MultiPoint...

Medtronic, Attain Performa, quadripolar leads

Medtronic Inc. announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of two additional Attain Performa left ventricular (LV) quadripolar leads. Both devices can be...

implantable cardioverter defibrillator, ep lab, leads, implantable devices

A new study evaluating Optim-insulated implantable cardioverter defibrillator (ICD) leads found low rates of all-cause mechanical failure during a median follow-up of 3.2 years.